戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 er transport rate of indospicine compared to arginine.
2 abolite 2-aminopimelic acid in comparison to arginine.
3 , is known as the Sakaguchi test and targets arginine.
4 ted by nitric oxide-dependent depletion of l-arginine.
5 n various ASS-deficient cancers by depleting arginine.
6 enile fish fed with graded levels of dietary arginine.
7 an enzyme that metabolizes l-citrulline to l-arginine.
8  predicted and confirmed an integral role of arginine(172), located in the 2nd extracellular loop, in
9 nd was not affected adversely by mutation of arginine(172).
10      ZNF326 is symmetrically dimethylated at arginine 175 (R175) and this modification is lost in a P
11 ygous TGM1 genotype had a mutation at either arginine 307 or 315, providing evidence that mutations a
12                                 Among these, arginines 35, 36 and 60 were the most frequently altered
13 oxide synthase inhibitor l-N(G)-monomethyl-l-arginine acetate (l-NMMA) into both femoral arteries rev
14 lts in a dramatic decrease in methylation of arginines adjacent to M6CK-phosphorylated amino acids.
15               Substitutions of the invariant arginine anchor residue in GAG result in global redistri
16                              Disrupting the 'arginine anchor' on CENP-C for the nucleosomal acidic pa
17 t coincide with the preference for P2 and P7 arginine anchors.
18                                 Decreases in arginine and citrulline and increases in ADMA were obser
19                                              Arginine and Glutamate-Rich protein 1 (ARGLU1) is a prot
20 r example, methylated derivatives of lysine, arginine and glutamine are readily accessible.
21 tained by diet and endogenous synthesis from arginine and glycine.
22                 Most nNOS inhibitors mimic l-arginine and have poor bioavailability.
23 is: sphingolipid metabolism (P=6.6x10(-5) ), arginine and proline metabolism (P=1.12x10(-7) ), glycer
24  pathway analysis, compounds associated with arginine and proline metabolism were found to be the mos
25 ers, making cells dependent on extracellular arginine and targetable by the arginine-degrading enzyme
26       Through coincubation with supplemental arginine and the arginine antagonist canavanine, we show
27 iation between consumption of the amino acid arginine and the rate of adverse birth outcomes using da
28           Consumption of amino acids such as arginine and tryptophan by immunoregulatory macrophages
29 R579W) and one that deletes three pathogenic arginines, and explored phenotypes of these lines alongs
30 ncubation with supplemental arginine and the arginine antagonist canavanine, we show that arginine av
31 rameters of pancreatic injury in mice with L-arginine AP.
32 s) residues of the hD4R are substituted with arginine (Arg) residues, cellular hD4R protein levels in
33 hism in ZC3HC1 (rs11556924), resulting in an arginine (Arg) to histidine (His) substitution in its en
34                         Here, we show that L-arginine (Arg) uptake through the host cell's SLC7A2-enc
35 the key enzyme that controls biosynthesis of arginine (Arg).
36 hism substitution from glutamine (Gln, Q) to arginine (Arg, R) at codon 460 of the purinergic P2X7 re
37  tonometry (EndoPAT), and plasma levels of l-arginine, arginase-1, and asymmetric dimethylarginine we
38   We find enrichment of glycine, valine, and arginine as both individual amino acids and as a part of
39 ctively, and 0.78 (95% CI: 0.64 to 0.97) for arginine at 1 month.
40 iated with the toothed whales or Odontoceti (arginine at 156) and baleen whales or Mysticeti (glutami
41 hat replaced the lysine at codon 110 and the arginine at codon 111 with alanine codons failed to repl
42  A2*05 allotype prefers the basic amino acid arginine at the second position of the peptide, and hydr
43 arginine antagonist canavanine, we show that arginine availability is a determinant of GBS cytotoxici
44                  Can1 mutants altered in the arginine-binding site or a cytosolic tripeptide sequence
45     RNA sequencing and qRT-PCR revealed that arginine biosynthesis genes (argR, argB, argC, argG, arg
46 conclude that by promoting the expression of arginine biosynthetic genes, especially argB gene, the c
47 tic stability by substituting the N-terminal arginine by norarginine.
48         First, we investigated the uptake of arginine by the cells of the biofilm as well as the meta
49 -Valentine leukocidin (PVL), SCCmec IVa, the arginine catabolic mobile element (ACME), and a specific
50 cumulation that results from the shunting of arginine catabolism into alternative nitrogen repositori
51  the biofilms, indicating active uptake, and arginine catabolites citrulline, ornithine, and putresci
52 ctions for specificity were also enriched in arginine CDR mutations, but these antibodies possessed s
53 eal unique hydrophobic environments near the arginine CDR mutations.
54 are governed by the relative contribution of arginine CDR residues to the overall antibody affinity.
55               Significant increases in urea, arginine, citrulline, asymmetric and symmetric dimethyla
56                             Plasma levels of arginine, citrulline, ornithine, asymmetric dimethylargi
57 ne substitution enhances the stability of an arginine-containing collagen peptide and provide a struc
58 lexes with a central binding cavity for twin-arginine-containing signal peptides.
59 lated properties studied, relative lysine to arginine content was found to be higher in CH1 and CL th
60                               Suppression of arginine-creatine metabolism by CKMT1-directed shRNAs or
61 phosphocreatine-mediated reactivation of the arginine-creatine pathway.
62 a thioether, or an extra amine group such as arginine, cysteine, lysine, methionine, and tryptophan h
63 extracellular arginine and targetable by the arginine-degrading enzyme pegylated arginine deiminase (
64                                              Arginine deiminase (ADI) inhibits growth in various ASS-
65                            Purpose Pegylated arginine deiminase (ADI-PEG 20) depletes essential amino
66 e by the arginine-degrading enzyme pegylated arginine deiminase (ADI-PEG 20).
67 ole of the arginine-lowering agent pegylated arginine deiminase (ADI-PEG20) has not been evaluated in
68  cristatus and P. gingivalis, and identified arginine deiminase (ArcA) of S. cristatus as the signali
69  (SAPP) derived from Streptococcus cristatus arginine deiminase (ArcA) was able to repress the expres
70                                      Protein arginine deiminase 2 (PAD2) plays a key role in the onse
71 ) to citrulline with recombinant polypeptide arginine deiminase 4 (PAD4) abolished ADAMDEC1-catalyzed
72                                     Peptidyl arginine deiminase 4 (PAD4), which binds proteins and ci
73 racellular trap formation involving peptidyl arginine deiminase 4.
74 enter phase 2 randomized clinical trial, the Arginine Deiminase and Mesothelioma (ADAM) study, was co
75 d decrease in the expression of genes in the arginine deiminase pathway during stringent response act
76                                     Peptidyl arginine deiminases have been shown to be hyperactive in
77 onal oxygenase activities, acting as both an arginine demethylase and a lysyl-hydroxylase.
78 JMJD6 functions directly or indirectly as an arginine demethylase of G3BP1 that promotes SG formation
79 sponse activation and increased virulence is arginine dependent.
80 d warrants further clinical investigation in arginine-dependent cancers.
81                         Randomization 2:1 to arginine deprivation (ADI-PEG20, 36.8 mg/m2, weekly intr
82 d with ASS1 immunohistochemistry, and longer arginine deprivation correlated with improved PFS.
83                Preclinical studies show that arginine deprivation is synthetically lethal in arginino
84 aled the significance of macrophage-mediated arginine deprivation to T cells.
85                               In this trial, arginine deprivation with ADI-PEG20 improved PFS in pati
86                              After 2 days of arginine deprivation, mTORC1 activity declined paralleli
87                                              Arginine derived biomolecules were found to involve in m
88 in the CCT domain, corresponding to an NF-YA arginine directly involved in CCAAT recognition, abolish
89 2-aminopimelic acid were more cytotoxic than arginine, displaying the highest toxicity in HepG2 liver
90  substitution of APP C-terminal lysines with arginine disrupts APP ubiquitination and that an increas
91 ells in G1, and this effect is mediated by l-arginine elimination rather than metabolite generation.
92 n, and inhibition of NO by N(G)-monomethyl-L-arginine enhanced intracellular survival of Mtb.
93       The beneficial effects of preoperative arginine-enriched dietary supplements (AES) are highly c
94 e after 6, 20, or 48 h of preincubation with arginine exhibited a recovery to higher pH.
95               This is the first report of an arginine finger observed in a septin and suggests that C
96 etween Hda monomers occludes the active site arginine finger, blocking its access to DnaA.
97 rs; (ii) mutational analysis reveals a trans-arginine finger, R158, indispensable for ATP hydrolysis;
98 mpatible with the location of the identified arginine finger.
99  mutations, suggesting that over-reliance on arginine for affinity leads to reduced specificity.
100                           On the other hand, arginine formed free Amadori product, free imidazolinone
101              However, the full repertoire of arginine GlcNAcylation induced by pathogen-delivered Nle
102 e derivatives, model systems of guanidine or arginine/glucose or (13)[C-6]-glucose were heated in aqu
103 ptor, generally alphavbeta6, via a conserved arginine-glycine-aspartic acid (RGD) motif in the expose
104 nt conformation beta5/beta3 integrins and an arginine-glycine-aspartic acid (RGD) sequence in the fir
105 ro by cell attachment to the high density of arginine-glycine-aspartic acid tripeptide present in DAP
106 e designed to mimic the tripeptide sequence (arginine-glycine-aspartic acid) of the natural ligands;
107 for a series of AMPA channels with different arginine/glycine (R/G) editing and flip/flop status.
108                     One such effector is the arginine glycosyltransferase NleB1 (NleB(CR) in C. roden
109 ature and pH but also by additives including arginine, guanidine, methionine, and thiocyanate.
110 ed interest is the mutation Histidine 147 to Arginine (H147R) in human TRiC subunit 5 (CCT5), which h
111 or the MARylation of glutamate/aspartate and arginine have been identified, the respective enzymes wi
112  to react with a small group of amino acids (arginine, histidine, lysine, phenylalanine, tyrosine, an
113 gR, argB, argC, argG, argH and argJ) and two arginine/histidine permease genes (SSA_1568 and SSA_1569
114                        Overall, we show that arginine improved pH homeostasis through a remodeling of
115  replaced mainly by cysteine, tryptophan and arginine in a codon-specific manner.
116 to give ethylene is promoted by binding of l-arginine in a nonoxidized conformation and of 2-oxogluta
117  single amino acid at position 112, which is arginine in apoE4 and cysteine in apoE3.
118            There is evidence that the use of arginine in dentifrices helps protect against caries.
119 as a significantly higher concentration than arginine in the fingerprint content of both males and fe
120 stigate the reactivity of free guanidine and arginine in the formation of imidazolinone derivatives,
121 osphine complex incorporating the amino acid arginine in the outer coordination sphere was immobilize
122 erine protease with a narrow specificity for arginine in the P1 position, which catalyzes the first e
123                               Citrulline and arginine increased significantly in HD compared to contr
124 tinuous and categorical associations between arginine intake and adverse birth outcomes.
125               The continuous associations of arginine intake with preterm birth before 37 weeks and w
126 al form of arginase (ARG2), which hydrolyzes arginine into ornithine and urea, is induced upon obesit
127 r ATP hydrolysis; (iii) the location of this arginine is conserved with the HerA/FtsK ATPase superfam
128                                    Targeting arginine is safe and warrants further clinical investiga
129 neurons, whereas mutagenesis of lysine 68 to arginine (K68R), mimicking deacetylation, increased acti
130                                              Arginine kinase (AK), which is a member of the phosphage
131        Among them, invertebrate tropomyosin, arginine kinase, myosin light chain, sarcoplasmic calciu
132 re, the generated acidic H2 O2 can oxidize l-Arginine (l-Arg) into NO for enhanced gas therapy.
133 esult in substitution of leucine-115 with an arginine (L115R) or deletion of the neighbouring leucine
134            Lys(129) mutation to glutamate or arginine led to misfolded protein that was degraded in v
135 lalanine, the latter of a size comparable to arginine, led to spectacular reductions of apparent Na(+
136 wed a serum amino acid signature composed of arginine, leucine/isoleucine, phenylalanine, tyrosine, v
137    These results indicate that 1.62% dietary arginine level improves glycolysis and fatty acid synthe
138 sulin signaling pathway, while 2.70% dietary arginine level led to inhibition of these genes.
139 ith the control group (0.87%), 2.31% dietary arginine level resulted in the upregulation of the relat
140                   Furthermore, 2.70% dietary arginine level significantly lowered GLUT2 and increased
141                                1.62% dietary arginine level significantly upregulated ACC, FAS and G6
142 s by increasing GK mRNA level; 2.70% dietary arginine level upregulated gluconeogenesis and resulted
143                                1.62% dietary arginine level upregulated glycolysis by increasing GK m
144                              The role of the arginine-lowering agent pegylated arginine deiminase (AD
145                                              Arginine, lysine, isoleucine, leucine, methionine, pheny
146 hook, and RK clusters (clusters enriched for arginine-lysine residues).
147 anced NO activity, because N(G)-monomethyl-l-arginine markedly blunted the flow response to obestatin
148 lline (800, 1600 mum) rescued NOx when the l-arginine media concentration was 25 mum but failed to do
149                              Under reduced l-arginine media conditions, HBECs treated with l-citrulli
150 nitric oxide synthase with N(omega) -nitro-l-arginine methyl ester.
151 ings reveal the importance of PRMT5-mediated arginine methylation during DSB repair pathway choice th
152  controlling about 85% of the total cellular arginine methylation in proteins.
153  regulating DNA repair; however, the role of arginine methylation in this process is poorly understoo
154                                              Arginine methylation is a common posttranslational modif
155 and mass spectrometry, we show that elevated arginine methylation of SRSF5 and lower phosphorylation
156 (PRMT5) complexed with MEP50/WDR77 catalyzes arginine methylation on histones and other proteins.
157                                              Arginine methylation on histones is a central player in
158 rginine methyltransferases (PRMTs) introduce arginine methylation, a post-translational modification
159 scription by attenuating the effect of local arginine methylation.
160                                      Protein arginine methyltransferase (PRMT) activity has been impl
161   However, a conclusive role for the protein arginine methyltransferase (PRMT) enzymes that catalyze
162 sferase 1 (CARM1) is a member of the protein arginine methyltransferase (PRMT) family and methylates
163                       Coactivator associated arginine methyltransferase 1 (CARM1) is a member of the
164              PRMT4 or coactivator-associated arginine methyltransferase 1 (CARM1) is a propitious tar
165                       Coactivator-associated arginine methyltransferase 1 (CARM1) is a protein methyl
166                                      Protein arginine methyltransferase 1 (PRMT1) is an essential enz
167 d receptor coactivator 1 (SRC1), and protein arginine methyltransferase 1 (PRMT1) only modestly incre
168       EYA1 physically interacts with protein arginine methyltransferase 1, which methylates EYA1 at t
169 tase-transcription activator EYA1 by protein arginine methyltransferase 1: mechanistic, functional, a
170  requires assembly factors united in protein arginine methyltransferase 5 (PRMT5) and survival motor
171                                      Protein arginine methyltransferase 5 (PRMT5) complexed with MEP5
172                                      Protein arginine methyltransferase 5 (PRMT5) is an emerging epig
173 kinases (M6CKs) bind subunits of the protein arginine methyltransferase 5 (PRMT5) molecular complex t
174                                      Protein arginine methyltransferase 7 (PRMT7) catalyzes the intro
175             Here we use mice lacking protein arginine methyltransferase 8 (PRMT8) in the brain to exa
176 recruitment of CARM1 not only adds a protein arginine methyltransferase activity to the ER-coactivato
177                                      Protein arginine methyltransferase enzyme 5 (PRMT5) regulates ma
178 h an shRNA screen, we identified the protein arginine methyltransferase Prmt1 as a vulnerable interve
179                         Here we identify the arginine methyltransferase PRMT5 as a key regulator of h
180 of Cancer Cell, Braun et al. report that the arginine methyltransferase PRMT5 is critical for tumor c
181                                  The type II arginine methyltransferase PRMT5 is responsible for the
182 ly modulates enzymatic activity of a protein arginine methyltransferase vital to abiotic stress toler
183                                  CARM1 is an arginine methyltransferase with diverse histone and non-
184 ng flagellar dynamics, we focused on protein arginine methyltransferases (PRMTs) 1, 3, 5, and 10.
185                                      Protein arginine methyltransferases (PRMTs) introduce arginine m
186 ification in eukaryotes catalyzed by protein arginine methyltransferases (PRMTs) that are typically t
187 rination activity more than any other single arginine mutation in yeast.
188                                       Single arginine mutations eliminated the fast interactions with
189              These findings demonstrate that arginine mutations in antibody CDRs display context-depe
190 ereas the less specific antibodies contained arginine mutations in more hydrophilic regions.
191 nine, we generated single, double and triple arginine mutations in RTA.
192       The more specific antibodies contained arginine mutations in the most hydrophobic portions of t
193 antibodies were much less dependent on their arginine mutations, suggesting that over-reliance on arg
194 Indospicine, a non-proteinogenic analogue of arginine, occurs only in Indigofera plant species and ac
195      Substitution of the active site binding arginine of CP2 to N-varepsilon-trimethyl-lysine or meth
196 ic arrangement and number of the lysines and arginines of the PBD vary among the lipins.
197 fferent variants or isoforms of tropomyosin, arginine or creatine kinase, glyceraldehyde-3-phosphate
198       We also found no effects with alanine, arginine, or a mixture of both amino acids.
199  activity against the substrate N-benzoyl-DL-arginine p-nitroanilide, is proposed as an alternative t
200 tively with arginase-1 and positively with l-arginine (P = .001).
201 membrane translocation, we synthesized seven arginine placement variants of LRLLRWC and compared thei
202                                              Arginine play numerous roles in several biological proce
203                            The toxic proline:arginine (PRn) poly-dipeptide encoded by the (GGGGCC)n r
204                   Here we report that serine-arginine protein kinase 2 (SRPK2) phosphorylates delta-s
205 re collected for 16S sequencing and targeted arginine quantification, and supernatants were prepared
206                  Here, we show that a single Arginine (R) to Glycine (G) mutation at position 76 in t
207     We previously showed that the amino acid arginine (R) within the sequence SRL (amino acids 445 to
208 g the genomically encoded glutamine (Q) with arginine (R); thus this editing site is referred to as t
209 tides including those containing an amidated arginine(R)-phenylalanine(F) motif at their C-termini (R
210 tween two short highly charged peptides-deca-arginine (R10) and deca-lysine (K10).
211             Glutamate E153 on the E-loop and arginine R210 on the adjacent subunit's backbone alpha-h
212                    One is the presence of an arginine R696 in the middle of the TM helix.
213        SLC38A9 mediates the transport, in an arginine-regulated fashion, of many essential amino acid
214                  The results show that these arginines relay critical information between the PCNA-bi
215                      Activation of mTORC1 by arginine requires SLC38A9, a poorly understood lysosomal
216 at mediate assembly, via interaction with an arginine residue at a similar register to these aspartic
217 e by substituting the highly conserved first arginine residue in transmembrane segment 4 (domain 1),
218 at the introduction of a single lipid-facing arginine residue near the middle of the beta barrel of t
219 e N terminus as well as a strictly conserved arginine residue toward the C terminus of ORF52 play cri
220 tion of cathepsin G or citrullination of the arginine residue within an LC3-interacting region motif
221 formed by stacking of the side chains of two arginine residues and by salt bridges formed between the
222                         Proteins with methyl arginine residues are also enriched at the tip and base
223  electrostatics; within this code lysine and arginine residues are non-equivalent and prenyl chain le
224                                              Arginine residues form a positively charged patch to bin
225 CR) in C. rodentium) that modifies conserved arginine residues in death domain-containing host protei
226 e that forms adducts on cysteine, lysine and arginine residues of proteins, thereby affecting their f
227 introduction of monomethylation marks at the arginine residues of substrate proteins.
228  target genes via symmetric dimethylation of arginine residues on histones H4R3, H3R8 and H2AR3.
229 lly cleave proteins C-terminal to lysine and arginine residues prior to LCMS/MS analysis of the resul
230         In particular, we identified several arginine residues that interact with the polyanionic sub
231 found that EHEC NleB1 glycosylated two GAPDH arginine residues, Arg(197) and Arg(200), and that these
232        Here, we demonstrate that 2 conserved arginine residues, R304 and R306, of EYA1 are essential
233 genetic modifications by methylating histone arginine residues.
234  N-varepsilon-trimethyl-lysine or methylated arginine results in cyclic peptide substrates, indicatin
235 lls adjust their metabolism when deprived of arginine revealed the significance of macrophage-mediate
236                                   SR (serine-arginine)-rich proteins influence multiple steps in mRNA
237 eracts with and hydroxylates multiple serine/arginine-rich (SR) proteins and SR related proteins, inc
238           We now identify an active role for arginine-rich domains in these phase separations.
239                                Expression of arginine-rich DPRs in cells induced spontaneous stress g
240                                        Short arginine-rich proteins called protamines mediate the nea
241 that binds with high affinity to serine- and arginine-rich splicing factor 2 (SRSF2), a crucial prote
242 r reader protein, in conjunction with serine/arginine-rich splicing factor 3 (SRSF3) and SRSF10.
243 or shuttling specific cargoes such as serine/arginine-rich splicing factors from the cytoplasm to the
244        The versatile functions of SR (serine/arginine-rich) proteins in pre-mRNA splicing and process
245  precursor proteins possess a conserved twin-arginine (RR) motif in their signal peptides that is inv
246 vation by cholesterol independently from its arginine-sensing function.
247 CFIm activator functions are mediated by the arginine-serine repeat (RS) domains of CFIm68/59, which
248                       Thus, through SLC38A9, arginine serves as a lysosomal messenger that couples mT
249 ux into the urea cycle and infusion of (15)N-arginine shows that Arg2 loss causes significant ammonia
250  small contribution of charge at a conserved arginine side chain previously suggested to form a salt
251      Variants of TP2 with shorter and longer arginine side-chain analogs translocate slower than TP2.
252 unction as the primary docking site for twin-arginine signal peptides.
253 ation of caspase proteases and inhibition of arginine-specific proteases.
254  both an ITIM mutation and either alanine or arginine substitutions had reduced titers and small plaq
255 ompared to that of the wild-type gBcyt while arginine substitutions had wild-type-like fusion levels
256                                 In contrast, arginine substitutions resulted in syncytia with only 2-
257                                  Alanine and arginine substitutions were used to determine if the pos
258 o Tat signal peptides with inactivating twin arginine substitutions.
259 rporation of (13) C/(15) N-lysine and (13) C-arginine such that each peptide derived from trypsin dig
260 est was reversible at any point by exogenous arginine, suggesting starved T cells remain poised await
261     ASS1 catalyzes the rate-limiting step of arginine synthesis in urea cycle and citrulline-nitric o
262    We observed specific up-regulation of the arginine synthesis pathway associated with overexpressio
263 cinate synthetase 1 (ASS1), a key enzyme for arginine synthesis, occurs in many cancers, making cells
264 pecificity is achieved by a cluster of three arginines that accommodates the terminal carboxyl group
265 s complex task, here we focused on conserved arginines that might play a central coordinating role in
266 tase 1 (ASS1) -negative tumors by converting arginine to citrulline and ammonia.
267  the H(+),K(+)-ATPase, the ability of the M8 arginine to donate an internal cation binding at the thi
268 unlike JM22, uses a tryptophan instead of an arginine to fill a critical notch between GIL and the HL
269 hesis: the transfer of an amidino group from arginine to glycine to form ornithine and guanidinoaceta
270  interface, one monomer supplied a catalytic arginine to the opposing subunit, greatly accelerating t
271  (the gene encoding the LiaS protein with an arginine-to-glycine change at position 135 [liaS(R135G)]
272                                           An arginine-to-histidine replacement at residue 435 in the
273 an populations and differs from PRDM9a by an arginine-to-serine change (R764S) in ZF9 and by replacem
274                                     The twin-arginine translocase (Tat) transports folded proteins ac
275                                         Twin-arginine translocation (Tat) systems transport folded pr
276 t surface display (YSD) screening and a twin-arginine translocation pathway selection.
277 hat transport-elicited ubiquitylation of the arginine transporter Can1 is promoted by transition to a
278 hift in the microbial community structure in arginine-treated biofilms as well as increased species d
279 ate the mechanistic and ecological effect of arginine treatment on the oral microbiome and its regula
280 ycin treatment, suggesting that the enhanced arginine uptake mediates AS II-induced wound healing.
281 ughout the vasculature, where it regulates L-arginine uptake.
282  activated via the TORC1 kinase complex upon arginine uptake.
283          Arginase-II (Arg-II), the type-II L-arginine-ureahydrolase, is highly expressed in pancreas.
284                                     Some DRY Arginine variants correlate with smell preferences in su
285  Receptor 2 suggested that a single lysine - arginine variation at the extracellular face of the rece
286 unction indicated that although the lysine - arginine variation between human and mouse orthologs had
287                In response to 1-desamino-8-D-arginine vasopressin (DDAVP), peak VWF:Ag levels exceede
288 sponsible for the clearance of misfolded pro-arginine vasopressin (proAVP) in the ER.
289                                              Arginine vasopressin colocalized with EGFP more often in
290 otropin-releasing hormone and do not express arginine vasopressin or oxytocin.
291                                Expression of arginine vasopressin receptor 1a (Avpr1a) and oxytocin r
292 dogenous NO production from the amino acid l-arginine, via nitric oxide synthase (NOS) enzymes, resea
293                                              Arginine was detected within the cells of the biofilms,
294 estigate the individual contribution of each arginine, we generated single, double and triple arginin
295                           Dietary intakes of arginine were assessed using repeated 24-hour recalls th
296 T3R3 hexamers loaded with both serotonin and arginine were obtained.
297 to K305 in human NHA2 has been replaced with arginine, which is a mutation that makes NapA electroneu
298         Some of the PC studies also included arginine, which may be abundant in insulin granules upon
299  and proline, glycine, glutamate, lysine and arginine, which were all consumed significantly faster.
300  KCl and the addition of flavor enhancers (l-arginine, yeast and oregano extract) on probiotic Prato

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top